Close
Nordic 9Nordic 9

Ulf Wiinberg (investor - Angel Investor)

Sweden
See something wrong or missing? Let us know
Offices:Copenhagen

Ulf Wiinberg used to be CEO at Lundbeck in Denmark

Average round investment:5M USD
Average number per year:1.0
Distribution: 2025 (1)
Portfolio companies: Sweden Sigrid Therapeutics
Mostly invests in: Sweden Sweden (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ulf Wiinberg

Name Criteria
Sweden Albert & Anna Göranssons Minne
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Hans Frykman
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Hillclimber
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Johan Markman
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Linc Invest
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Mikael Lönn
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden nxt2b - Nexttobe AB
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Rolf Bjerndell
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Stassi Anastassov
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Ulf Landegren
73%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top